1.
Reich K, Blauvelt A, Thaci D, Leonardi C, Poulin Y, Burge D, Peterson L, Arendt C, Gottlieb AB. Maintenance of Response with Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: 48-Week Results from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). J of Skin [Internet]. 2017Oct.27 [cited 2022May16];1(3.1):s23. Available from: https://www.jofskin.org/index.php/skin/article/view/125